Tumour mutational burden as a driver for treatment choice in resistant tumours (and beyond)
Melissa Bersanelli
Topics & Concepts
PembrolizumabMedicineOncologyInternal medicineFood and drug administrationBiomarkerCancerFamily medicineImmunotherapyPharmacologyBiochemistryChemistryCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations